SYNOPSIS

Uniquely this year, the group took stock of the enormous impact of the COVID-19 pandemic on science, technology, policy, consumer expectations, and the healthcare system as a whole. In addition, sessions dug deep into precision oncology, data and learning systems, and evidence development in the genetic testing space.

In particular, three impactful themes emerged that differentiated the discussion from previous meetings.

1. The COVID-19 pandemic sent clinical diagnostics and digital health infrastructure trends into overdrive.

2. Evidence development is undergoing a radical and irrevocable change in response to a growing appetite for rapid, targeted, distributed clinical trials and real world evidence.

3. Democratization of healthcare through access to technology is accelerating.

Each of these is unpacked in the paper, and a call for case studies at the upcoming Summit is issued.